New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 1, 2013
12:48 EDTMDVNMedivation price target raised to $70 from $62 at Wedbush
Wedbush raised Medivation's price target citing solid U.S. Xtandi sales. Share are Outperform rated.
News For MDVN From The Last 14 Days
Check below for free stories on MDVN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 11, 2014
07:50 EDTMDVNPotential of Medivation Xtandi underappreciated, says Bernstein
Subscribe for More Information
07:37 EDTMDVNMedivation to host conference call
Conference call to discuss FDA approval of XTANDIŽ to be held on September 11 at 8:30 am. Webcast Link
07:11 EDTMDVNMedivation price target raised to $112 from $89 at Stifel
Subscribe for More Information
September 10, 2014
16:41 EDTMDVNMedivation to resume trading at 4:50 pm ET
Subscribe for More Information
16:26 EDTMDVNMedivation receives $90M milestone payment after FDA approves XTANDI indication
Subscribe for More Information
15:16 EDTMDVNMedivation Xtandi efficacy supplement posted to FDA website
Subscribe for More Information
14:48 EDTMDVNMedivation trading halted, pending news
Subscribe for More Information
September 9, 2014
10:10 EDTMDVNOn the Fly: Analyst Upgrade Summary
Subscribe for More Information
08:42 EDTMDVNMedivation upgraded at Bernstein
Subscribe for More Information
06:43 EDTMDVNMedivation upgraded to Outperform from Market Perform at Bernstein
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use